-
Guggenheim Reiterates "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM)
来源: Buzz FX / 28 2月 2025 10:51:14 America/Chicago
Guggenheim Reiterates "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM) Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "buy" rating reiterated by G
Read more...